[symposium-mail]
Recent Posts
- Study suggests BMPER protein as treatment target in PAH
- I’ve discovered a new tool to avoid triggers: ‘glimmers’
- Combination therapy effective in PAH with heart disease risk factors
- Liquidia gets $50M more after first sale of Yutrepia to treat PH
- Phase 3 PAH trial of ralinepag fully enrolled, results expected in 2026